Mouse senile amyloid deposition is suppressed by adenovirus-mediated overexpression of amyloid-resistant apolipoprotein A-II

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1319-1326

  Chiba, Takuya ^a,d   Kogishi, Kumiko ^a   Wang, Jing ^a   Xia, Cher ^a   Matsushita, Takatoshi ^a   Miyazaki, Jun Ichi ^b   Saito, Izumu ^c   Hosokawa, Masanori ^a   Higuchi, Keiichi ^d  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN A2; VIRUS VECTOR;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLUOROMETRY; GENE OVEREXPRESSION; GENE TARGETING; GENE TRANSFER; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0032878280     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65234-0     Document Type: Article

References (37)

1. Sipe JD: Amyloidosis. Annu Rev Biochem 1992, 61:947-975
2. SAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem 1986, 261:12834-12840
3. SAM) and human apolipoprotein A-II. FEBS Lett 1986, 203:149-152
4. SAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1991, 60:231-238
5. HogenEsch H, Niewold TA, Higuchi K, Tooten PC, Gruys E, Radl J: Gastrointestinal AAPOAII, and systemic AA-amyloidosis in aged C57BL/Ka mice: amyloid-type dependent effect of long-term immunosuppressive treatment. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 64:37-43
6. Shimizu K, Morita H, Niwa T, Maeda K, Shibata M, Higuchi K, Takeda T: Spontaneous amyloidosis in senile NSY mice. Acta Pathol Jpn 1993, 43:215-221
7. Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M, Takeda T: Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem J 1991, 279:427-433
8. Naiki H, Higuchi K, Shimada A, Takeda T, Nakakuki K: Genetic analysis of murine senile amyloidosis Lab Invest 1993, 68:332-337
9. c reduces the plasma level and the size of high density lipoprotein. FEBS Lett 1993, 317:207-210
10. Higuchi K, Naiki H, Kitagawa K, Kitado H, Kogishi K, Matsushita T, Takeda T: Apolipoprotein A-II gene, and development of amyloidosis, and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II. Lab Invest 1995, 72:75-82
11. Higuchi K, Kogishi K, Wang J, Chen X, Chiba T, Matsushita T, Hoshii Y, Kawano H, Ishihara T, Yokota T, Hosokawa M: Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 1998, 78:1535-1542
12. Jarrett JT, Berger EP, Lansbury PJ: The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697
13. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B: Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995, 375:698-700
14. Niewold TA, Hol PR, van AA, Lutz ET, Gruys E: Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987, 56:544-549
15. Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P: Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Commun 1994, 199:306-312
16. Naiki H, Higuchi K, Nakakuki K, Takeda T: Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest 1991, 65:104-110
17. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108: 193-199
18. Higuchi K, Wnag J, Kitagawa K, Matsushita T, Kogishi K, Naiki H, Kitado H, Hosokawa M: Accelerated senile amyloidosis induced by amyloidogenic apoA-II gene shortens the life span of mice but does not accelerate the rate of senescence. J Gerontol 1996, 51A:B295-B302
19. Kunisada T, Higuchi K, Aota S, Takeda T, Yamagishi H: Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). Nucleic Acids Res 1986, 14:5729-5740
20. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I: Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996, 93:1320-1324
21. Kanegae Y, Makimura M, Saito I: A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994, 47:157-166
22. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995, 23:3816-3821
23. Pras M, Zucker-Franklin D, Rimon A, Franklin EC: Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. J Exp Med 1969, 130:777-791
24. Naiki H, Higuchi K, Hosokawa M, Takeda T: Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 1989, 177:244-249
25. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K, Takeda T: Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 1983, 48:231-240
26. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ: Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993, 261:469-472
27. Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R: Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997, 1339:143-154
28. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB: Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 1996, 10: 1736-1750
29. Wood SJ, Wetzel R, Martin JD, Hurle MR: Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry 1995, 34:724-730
30. Soto C, Kindy MS, Baumann M, Frangione B: Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem Biophys Res Commun 1996, 226:672-680
31. Miroy GJ, Lai Z, Lashuel HA, Peterson SA, Strang C, Kelly JW: Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci USA 1996, 93:15051-15056
32. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM, Frangione B: Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 1998, 4:822-826
33. Gonnerman WA, Elliott-Bryant R, Carreras I, Sipe JD, Cathcart ES: Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene. J Exp Med 1995, 181:2249-2252
34. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM: In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994, 269:13695-13702
35. Kozarsky KF, Jooss K, Donahee M, Strauss JF, Wilson JM: Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat Genet 1996, 13:54-62
36. Gravel C, Gotz R, Lorrain A, Sendtner M: Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat Med 1997, 3:765-770
37. Riley DJ, Nikitin AY, Lee WH: Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb± mice. Nat Med 1996, 2:1316-1321